-
Something wrong with this record ?
Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males
L. Eremiasova, JA. Hubacek, V. Danzig, V. Adamkova, L. Mrazova, J. Pitha, V. Lanska, R. Cífková, L. Vitek
Language English Country Japan
Document type Journal Article
NLK
Free Medical Journals
from 2002
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
from 2002
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
from 2002
Open Access Digital Library
from 2002-01-01
- MeSH
- Bilirubin blood MeSH
- Adult MeSH
- Genotype MeSH
- Gilbert Disease blood epidemiology genetics MeSH
- Glucuronosyltransferase genetics MeSH
- Myocardial Infarction blood epidemiology genetics MeSH
- Middle Aged MeSH
- Humans MeSH
- Polymorphism, Genetic MeSH
- Prevalence MeSH
- Promoter Regions, Genetic MeSH
- Prospective Studies MeSH
- Cross-Sectional Studies MeSH
- Retrospective Studies MeSH
- Risk Factors MeSH
- Sex Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: The potential antiatherogenic role of bilirubin is generally acknowledged, so the aim of this study was to determine serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in the Czech general population with particular reference to its relationship to the risk of myocardial infarction (MI).Methods and Results:Biochemical markers were analyzed in 2 independent Czech post-MONICA studies (in total, n=3,311), and in 741 male MI patients. TheUGT1A1promoter gene variant (rs81753472) was analyzed in these MI patients and in the first control population cohort (n=717). Medians of serum bilirubin concentrations in the 2 Czech general population cohorts were 9.6 and 9.8 μmol/L (10.7 and 11.3 μmol/L in males, and 8.3 and 8.8 μmol/L in females; P<0.01). The prevalence of GS was 8.9%, twice as high in males compared with females (11.6 vs. 6.1%; P<0.01). TheUGT1A1(TA)7/7promoter repeats significantly influenced serum bilirubin concentrations in the controls, but not in the MI patients. Serum bilirubin concentrations were significantly lower in MI patients (7.7 vs. 10.7 μmol/L; P<0.01), with almost 5-fold lower prevalence of GS. CONCLUSIONS: Serum bilirubin concentrations and the prevalence of GS were determined in the Czech general population. Significantly lower serum bilirubin concentrations were observed in male MI patients.
Center for Experimental Medicine Institute for Clinical and Experimental Medicine
Department of Preventive Cardiology Institute for Clinical and Experimental Medicine
Medical Statistics Unit Institute for Clinical and Experimental Medicine
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004847
- 003
- CZ-PrNML
- 005
- 20220127144926.0
- 007
- ta
- 008
- 220113s2020 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1253/circj.CJ-20-0192 $2 doi
- 035 __
- $a (PubMed)32848115
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Eremiasova, Lenka $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University $u 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University
- 245 10
- $a Serum Bilirubin in the Czech Population - Relationship to the Risk of Myocardial Infarction in Males / $c L. Eremiasova, JA. Hubacek, V. Danzig, V. Adamkova, L. Mrazova, J. Pitha, V. Lanska, R. Cífková, L. Vitek
- 520 9_
- $a BACKGROUND: The potential antiatherogenic role of bilirubin is generally acknowledged, so the aim of this study was to determine serum bilirubin concentrations and the prevalence of Gilbert syndrome (GS) in the Czech general population with particular reference to its relationship to the risk of myocardial infarction (MI).Methods and Results:Biochemical markers were analyzed in 2 independent Czech post-MONICA studies (in total, n=3,311), and in 741 male MI patients. TheUGT1A1promoter gene variant (rs81753472) was analyzed in these MI patients and in the first control population cohort (n=717). Medians of serum bilirubin concentrations in the 2 Czech general population cohorts were 9.6 and 9.8 μmol/L (10.7 and 11.3 μmol/L in males, and 8.3 and 8.8 μmol/L in females; P<0.01). The prevalence of GS was 8.9%, twice as high in males compared with females (11.6 vs. 6.1%; P<0.01). TheUGT1A1(TA)7/7promoter repeats significantly influenced serum bilirubin concentrations in the controls, but not in the MI patients. Serum bilirubin concentrations were significantly lower in MI patients (7.7 vs. 10.7 μmol/L; P<0.01), with almost 5-fold lower prevalence of GS. CONCLUSIONS: Serum bilirubin concentrations and the prevalence of GS were determined in the Czech general population. Significantly lower serum bilirubin concentrations were observed in male MI patients.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a bilirubin $x krev $7 D001663
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a Gilbertova nemoc $x krev $x epidemiologie $x genetika $7 D005878
- 650 _2
- $a glukuronosyltransferasa $x genetika $7 D014453
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a infarkt myokardu $x krev $x epidemiologie $x genetika $7 D009203
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a prevalence $7 D015995
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sexuální faktory $7 D012737
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hubacek, Jaroslav A $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Danzig, Vilém $u 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University
- 700 1_
- $a Adamkova, Věra $u Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Mrazova, Lenka $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Pitha, Jan $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Lanska, Věra $u Medical Statistics Unit, Institute for Clinical and Experimental Medicine
- 700 1_
- $a Cífková, Renata $u 2nd Department of Internal Medicine, Faculty General Hospital and 1st Faculty of Medicine, Charles University $u Center for Cardiovascular Prevention, 1st Faculty of Medicine and Thomayer Hospital, Charles University
- 700 1_
- $a Vitek, Libor $u Institute of Medical Biochemistry and Laboratory Diagnostics, Faculty General Hospital and 1st Faculty of Medicine, Charles University $u 4th Department of Internal Medicine, 1st Faculty of Medicine Faculty and General Hospital, Charles University
- 773 0_
- $w MED00007056 $t Circulation journal : official journal of the Japanese Circulation Society $x 1347-4820 $g Roč. 84, č. 10 (2020), s. 1779-1785
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32848115 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127144923 $b ABA008
- 999 __
- $a ok $b bmc $g 1752142 $s 1155996
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 84 $c 10 $d 1779-1785 $e 20200826 $i 1347-4820 $m Circulation journal $n Circ J $x MED00007056
- LZP __
- $a Pubmed-20220113
